Table 6.
Comparison of clinical characteristic, laboratory abnormalities and complications between survival and non survival group (n = 88)
| Survived (n = 79) | Died (n = 9) | P valuea | |
| Oliguria, n (%) | 62 (78.5) | 8 (88.9) | 0.679 |
| Hematuria, n (%) | 44 (55.7) | 4 (44.4) | 0.726 |
| Anemia, n (%) | 64 (81) | 7 (77.8) | 1.000 |
| Leukocytosis, n (%) | 57 (72.2) | 9 (100) | 0.105 |
| Thrombocytopenia, n (%) | 37 (46.8) | 5 (55.6) | 0.731 |
| Hyperkalemia, n (%) | 19 (24.1) | 3 (33.3) | 0.685 |
| Metabolic acidosis, n (%) | 29 (36.7) | 6 (66.7) | 0.147 |
| Hypoalbuminemia, n (%) | 46 (58.2) | 8 (88.9) | 0.145 |
| Hepatic dysfunction, n (%) | 32 (40.5) | 4 (44.4) | 1.000 |
| Hemolysis, n (%) | 67 (84.8) | 8 (88.9) | 1.000 |
| Rhabdomyolysis, n (%) | 55 (69.6) | 5 (55.6) | 0.457 |
| Pneumonia/ARDS, n (%) | 3 (3.8) | 5 (55.6) | 0.001 |
| Seizure/Encephalopathy, n (%) | 5 (6.3) | 4 (44.1) | 0.005 |
| Multiorgan failure, n (%) | 2 (2.5) | 2 (22.2) | 0.050 |
| ICU support, n (%) | 5 (6.3) | 5 (55.6) | 0.001 |
| Dialysis, n (%) | 57 (72.2) | 9 (100) | 0.105 |
a
χ2 with Fisher’s Extact test. ICU: Intensive care unit; ARDS: Acute respiratory distress syndrome.